Tamiflu was a blockbuster product for Roche over a ... Tamiflu has been approved in New Zealand as an OTC drug since 2007, and that will likely assist Sanofi as it tries to persuade the FDA ...

On Friday, Sanofi SA (NASDAQ:SNY ... Opella is the world’s third-largest company in the over-the-counter and vitamins, minerals, and supplements market, serving over 500 million consumers ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

This Company Profile from Euromonitor provides key details and analysis of Sanofi, the French pharmaceutical company, in the worldwide consumer health market. In 2022, Sanofi saw strong growth in ...

Opella, an arm of Sanofi that manufactures popular over-the-counter products including Doliprane painkillers, Dulcolax laxatives, and various medicines and vitamins, is being split off from its ...

Sanofi is one of the biggest players in the Allergy category globally. But in the UK its portfolio was still underrepresented. Aware of a high level of dissatisfaction from UK allergy sufferers with ...